Endo Int'l Plc (ENDP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.2926 -0.0154 (-5.00%) 08/25/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.2926 unch (unch) -
for Thu, Aug 25th, 2022
Results
download Want to compare other data? Select FieldsSymbol | ENDP | GALT | GANX | ||
Company | Endo Int'l Plc | Galectin Therapeutic | Gain Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.3027 | 1.1500 | 2.47 | ||
High | 0.3059 | 1.1900 | 2.47 | ||
Low | 0.2805 | 1.0700 | 2.16 | ||
Last | 0.2926 | 1.1000 | 2.30 | ||
Change | -0.0154 | -0.0300 | -0.14 | ||
% Change | -5.00% | -2.65% | -5.74% | ||
Volume | 44,437,200 | 467,400 | 235,800 | ||
20-Day Average Volume | 71,590,477 | 1,587,150 | 263,120 | ||
Previous Close | 0.3080 | 1.1300 | 2.44 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 0.4538 | 1.4315 | 1.91 | ||
20-Day Raw Stochastic | 1.91% | 22.89% | 69.59% | ||
20-Day Relative Strength | 40.99% | 33.78% | 58.55% | ||
Weighted Alpha | -66.99 | -26.98 | -50.08 | ||
Today's Opinion | 88% Sell | 100% Sell | 40% Buy | ||
Previous Opinion | 88% Sell | 100% Sell | 40% Buy | ||
Last Month's Opinion | 100% Sell | 8% Sell | 8% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -27.88% since 08/18/22 | -5.98% since 01/02/25 | -0.86% since 01/02/25 | ||
Low | 0.2805 on 08/25/22 | 1.0700 on 01/10/25 | 2.13 on 01/07/25 | ||
High | 0.5900 on 08/19/22 | 1.2900 on 01/06/25 | 2.53 on 01/06/25 | ||
1-Month | |||||
%Chg | -34.98% since 07/25/22 | -43.01% since 12/10/24 | +35.29% since 12/10/24 | ||
Low | 0.2800 on 08/17/22 | 0.7260 on 12/20/24 | 1.50 on 12/20/24 | ||
High | 0.9400 on 08/03/22 | 2.3600 on 12/16/24 | 2.65 on 01/02/25 | ||
3-Month | |||||
%Chg | -26.35% since 05/25/22 | -57.36% since 10/10/24 | +16.75% since 10/10/24 | ||
Low | 0.2800 on 08/17/22 | 0.7260 on 12/20/24 | 1.50 on 12/20/24 | ||
High | 0.9400 on 08/03/22 | 3.1700 on 11/11/24 | 3.19 on 10/17/24 | ||
6-Month | |||||
%Chg | -91.00% since 02/25/22 | -52.99% since 07/10/24 | +91.67% since 07/10/24 | ||
Low | 0.2800 on 08/17/22 | 0.7260 on 12/20/24 | 0.89 on 08/13/24 | ||
High | 3.2800 on 02/28/22 | 3.1700 on 11/11/24 | 3.19 on 10/17/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 68,803 | 70,921 | 64,721 | ||
Shares Outstanding, K | 235,143 | 62,762 | 26,525 | ||
Annual Sales | 2,993,210,000 | 0 | 60,000 | ||
Annual Net Income | -613,250,000 | -41,070,000 | -22,270,000 | ||
Last Quarter Sales | 569,110,000 | 0 | 0 | ||
Last Quarter Net Income | -1,885,430,000 | -11,220,000 | -4,490,000 | ||
60-Month Beta | 1.15 | 0.83 | 0.14 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.03 on 08/09/22 | -0.18 on 11/14/24 | -0.17 on 11/14/24 | ||
Latest Earnings Date | 08/11/22 | 11/18/24 | 11/12/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.13 | 0.00 | 0.00 |